# A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis

> **NCT00055133** · PHASE2 · COMPLETED · sponsor: **Angiotech Pharmaceuticals** · enrollment: 50 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Micellar Paclitaxel for Injection

## Key facts

- **NCT ID:** NCT00055133
- **Lead sponsor:** Angiotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 50 (—)
- **Last updated:** 2008-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055133, "A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00055133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*